| FDA: Merck drug may have suicide link |
|
|
|
WASHINGTON (AP) - The Food and Drug Administration says it's investigating a possible link between the allergy drug Singulair and suicide. FDA said it is reviewing reports of mood changes, suicidal behavior and suicide in patients who have taken the drug. Singulair was drug maker Merck's best-selling product last year. In the past year Merck has updated the drug's labeling four times to include information on tremors, anxiousness, depression and suicidal behavior reported in some patients. Singulair had sales of more than $4 billion last year. Merck shares had fallen by 10 cents in late morning trading.
Please Enter New Tags Separated By Comma's
Or Close 
      |
Latest Forum Posts
Most recent comments
| I am in a dark place holding my candlelight...I feel like bl... |
| More... |
| I feel like I never sleep. I just keep replaying things in m... |
| More... |
Popular Pages
Popular this week
Tag Cloud
adhd adolescents alcoholism anorexia antidepressant Antidepressants anxiety bipolar disorder bulimia bullying caregiving Celexa childhood depression children and depression christmas cognitive behavioral therapy college students depressed teens depression depression and celebrities depression and teenagers depression screening depression symptoms depression test depression treatment elderly exercise family therapy fitness gastrointestinal bleeding health insurance holiday blues holiday depression holidays meditation mental health mental illness military online support group post traumatic stress disorder postpartum depression posttraumatic stress disorder pregnancy prescription drugs prozac psychiatrist psychologist psychotherapy ptsd risk factors sad schizophrenia seasonal affective disorder seniors soldiers SSRIs stress suicide suicide rates support group talk therapy teenagers teens teens and depression therapist therapy virtual iraq wellbutrin wellness winter blues women and depression work work and stress workplace zyprexa
Copyright© Deborah Gray
Except where otherwise noted, this work is licensed under a Creative Commons License.
This information is meant to support, not replace, the relationship between a reader and his/her doctor. We do not collect, distribute, or sell any information about visitors to this site. And we do not retain or re-distribute personal information, including the email address, of anyone who writes to us. Wing of Madness accepts no corporate subsidy of any kind.